150 Participants Needed

ClearPetra for Kidney Stones

(VA-UAS vs trad Trial)

JL
Overseen ByJane Ledesma
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Kansas Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Ureteroscopy has been considered the best approach when treating renal stones smaller than 2 cm. This procedure is usually performed together with ureteral access sheaths, which helps protect the ureter mucosa and lowers intrarenal pressure.Recently, a new vacuum-assisted ureteral access sheath called ClearPetra has entered US market and allows for continuous stone fragmentation and aspiration.Because there is little information on comparing this device with traditional approach (no sheath or non-vacuum-assisted sheath) in American population, we aim to compare those devices in terms of their ability to clear the kidney from kidney stones, as well as reduce infection rates postoperatively.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is the ClearPetra Vacuum-assisted Ureteral Access Sheath safe for use in humans?

The ClearPetra device has been used in procedures for kidney stones, and its safety has been reported in some studies, although there are still questions about the safety of ureteral access sheaths in general. Some research has looked at potential injuries to the ureter (the tube connecting the kidney to the bladder) from using these sheaths, but specific safety data for ClearPetra is limited.12345

How is the ClearPetra treatment different from other treatments for kidney stones?

The ClearPetra Vacuum-assisted Ureteral Access Sheath is unique because it allows for continuous stone fragmentation and removal while maintaining a clear view during the procedure, which can reduce operation time and improve efficiency compared to traditional methods.16789

What data supports the effectiveness of the ClearPetra Vacuum-assisted Ureteral Access Sheath treatment for kidney stones?

Research shows that the ClearPetra sheath allows for continuous stone removal and a clear view during procedures, and has been successfully used in a case of ureteroscopic lithotripsy for a large ureteral stone. Additionally, similar vacuum-assisted techniques have been effective in managing kidney stones by improving stone clearance and controlling pressure during surgery.1391011

Who Is on the Research Team?

WM

Wilson Molina, MD

Principal Investigator

Study Principal Investigator

Are You a Good Fit for This Trial?

This trial is for individuals with kidney stones smaller than 2 cm who are undergoing ureteroscopy. The study aims to include those who can benefit from a new device designed to improve the procedure and potentially reduce postoperative infections.

Inclusion Criteria

I am over 18 years old.
Total stone burden between 1.0 to 2.5 cm
I am scheduled for a specific kidney stone removal surgery.

Exclusion Criteria

I have a bleeding disorder that hasn't been treated.
I am having surgery to remove kidney stones from both sides at once.
Chronic external urinary catheters
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants undergo retrograde intrarenal surgery (RIRS) with either the ClearPetra™ vacuum-assisted ureteral access sheath or a traditional approach

1 day
1 visit (in-person)

Follow-up

Participants are monitored for stone-free status and urinary tract infection postoperatively

90 days
Multiple visits (in-person and virtual)

What Are the Treatments Tested in This Trial?

Interventions

  • ClearPetra™ Vacuum-assisted Ureteral Access Sheath
Trial Overview The ClearPetra vacuum-assisted ureteral access sheath is being tested against traditional methods (no sheath or non-vacuum-assisted sheaths) in American patients, focusing on its efficiency in stone removal and infection rate reduction after surgery.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: 1. RIRS WITH VACUUM-ASSISTED URETERAL ACCESS SHEATHActive Control1 Intervention
Group II: 2. RIRS WITH TRADITIONAL APPROACHActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Kansas Medical Center

Lead Sponsor

Trials
527
Recruited
181,000+

Published Research Related to This Trial

In a study of 136 patients, vacuum-assisted percutaneous nephrolithotomy (Va-PCNL) demonstrated a significantly shorter operative time (95 minutes) compared to standard mini-PCNL (146 minutes), making it a more efficient option for kidney stone treatment.
Both Va-PCNL and mini-PCNL had similar stone-free rates (around 72%) and complication rates, but Va-PCNL resulted in a shorter hospital stay (1.7 days vs. 2.7 days), indicating it may offer advantages in recovery time without compromising safety or efficacy.
Vacuum-assisted access sheath in supine mini-percutaneous nephrolithotomy (mini-PCNL).Szczesniewski, JJ., Boronat Catalá, J., García-Cano Fernández, AM., et al.[2023]

Citations

A new method for effective use of the ClearPetra ureteral access sheath for a giant ureteral stone. [2023]
Vacuum-assisted access sheath in supine mini-percutaneous nephrolithotomy (mini-PCNL). [2023]
Vacuum-assisted mini-percutaneous nephrolithotomy: a new perspective in fragments clearance and intrarenal pressure control. [2021]
RIRS with Vacuum-Assisted Ureteral Access Sheath versus MPCNL for the Treatment of 2-4 cm Renal Stone. [2022]
Impact of ureteric access sheath use during flexible ureteroscopy: A comparative study on efficacy and safety. [2023]
Prospective evaluation and classification of ureteral wall injuries resulting from insertion of a ureteral access sheath during retrograde intrarenal surgery. [2022]
Impact of ureteral access sheath on renal stone treatment: prospective comparative non-randomised outcomes over a 7-year period. [2021]
A Pilot Study of a Novel Syphon Ureteral Access Sheath Shows Potential to Reduce Renal Pressures and Improve Irrigant Flow. [2023]
Ureteral access strategies: pro-access sheath. [2014]
Intrarenal pressure and irrigation flow with commonly used ureteric access sheaths and instruments. [2020]
The use of a ureteral access sheath does not improve stone-free rate after ureteroscopy for upper urinary tract stones. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security